Qitan Technology
Chengdu
About Qitan Technology
Developer of a genome sequencing technology. The company takes advantage of nanopores to sequence single nucleic acid molecules.Using innovative nanopore gene sequencing technology, it provides single-molecule sequencing capability with long reading length, real-time output of sequencing results, low single-running cost, small and convenient instrument, and cost-effective gene sequencing solution without complicated library preparation. It can directly detect the apparent modification of nucleic acids and expand the application of gene sequencing technology in cutting-edge biological research and clinical medicine such as instant diagnosis, metagenomics, epigenetics, RNA and transcriptomics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $196.9M
- Funding stage: Late Stage Venture
- Last round: Series C (Dec 2023)
- Website: qitantech.com
- Phone: 028-65225131
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/qitan-technology-92786 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.